Literature DB >> 5170652

Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.

J C Heuson, C Waelbroeck, N Legros, G Gallez, C Robyn, M L'Hermite.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5170652     DOI： 10.1159/000301858

Source DB:  PubMed          Journal:  Gynecol Invest        ISSN： 0017-5986


× No keyword cloud information.
  6 in total

1.  Comparative trial of nafoxidine and ethinyloestradiol in advanced breast cancer: an E.O.R.T.C. study.

Authors:  J C Heuson; E Engelsman; J Blonk-Van Der Wijst; H Maass; A Drochmans; J Michel; H Nowakowski; A Gorins
Journal:  Br Med J       Date:  1975-06-28

2.  The prophylaxis of rat and mouse mammary gland tumorigenesis by suppression of prolactin secretion: a reappraisal.

Authors:  C W Welsch; M Goodrich-Smith; C K Brown; L Roth
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

3.  Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors.

Authors:  P G Spinola; B Marchetti; Y Mérand; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-12       Impact factor: 4.872

4.  Endogenous peroxidase: specific marker enzyme for tissues displaying growth dependency on estrogen.

Authors:  W A Anderson; Y H Kang; E R DeSombre
Journal:  J Cell Biol       Date:  1975-03       Impact factor: 10.539

5.  Estrogen and antagonist-induced changes in endometrial topography of immature and cycling rats.

Authors:  W A Anderson; Y H Kang; E R DeSombre
Journal:  J Cell Biol       Date:  1975-03       Impact factor: 10.539

Review 6.  Milk: an epigenetic amplifier of FTO-mediated transcription? Implications for Western diseases.

Authors:  Bodo C Melnik
Journal:  J Transl Med       Date:  2015-12-21       Impact factor: 5.531
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.